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Abstract
To address whether altered erythropoietin (EPO) synthesis might be involved in prenatal pig
mortality, studies were conducted to measure porcine embryonic EPO mRNA expression during
early gestation (days 24–40). Three pig models differing in embryonic survival from days 24–40
were investigated: intact white crossbred gilts (INT), white crossbred gilts that were unilaterally
hysterectomized-ovariectomized before puberty and whose pregnant uterus constituted a crowded
environment (UHO), and prolific, intact Meishan gilts (ME). A partial cDNA for porcine EPO,
developed via reverse transcription and polymerase chain reaction procedures was used to generate
a 32P-labeled probe for use in Northern analyses. In an initial study, embryonic liver EPO mRNA
was greatest on day 24, decreased by day 30 (P < 0.01), and was barely detectable by day 40.
EPO mRNA expression was not influenced by pig model. Placental EPO mRNA expression was
detectable in only 4 of 53 placentae examined. In a second study at day 35 of gestation, embryonic
liver EPO mRNA expression was measured in the same three pig models and in two embryos of
divergent weights from each gilt. Meishan embryos had lower (P < 0.01) plasma immunoassayable
EPO concentrations (P = 0.04) and higher survival rates (87 ± 2.7%) at day 35 than did white
crossbred embryos (75±5%). Liver EPO mRNA expression did not differ among animal models, nor
did plasma EPO or tissue EPO mRNA expression differ between large and small embryos. There was
no apparent relationship between embryonic development, measured as embryonic and placental
size, and plasma EPO concentrations or liver EPO mRNA expression. These results indicate that
at the gestational ages examined, the embryonic liver is one source of plasma erythropoietin and
suggest that at the ages sampled, EPO is not a limiting factor in embryonic development. Published
by Elsevier Science B.V.
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1. Introduction
Prenatal mortality in swine can be as great as 50%. On the average, 20–30% of fetuses
die before day 30 and another 10–20% from day 40 to term (Pope, 1994). When the uterine
environment is artificially crowded, additional mortality occurs between days 25 and 40 of
gestation (Webel and Dziuk, 1974; Knight et al., 1977). Chinese Meishan pigs have increased
litter sizes compared with contemporary white crossbreds due to increased ovulation rates
and enhanced prenatal survival throughout gestation (Christenson et al., 1993). Enhanced
ME embryonic survival has been measured at day 30 of gestation (Bazer et al., 1988).
Erythropoiesis in swine fetuses undergoes dramatic maturational changes during days
25–40 of gestation (Pearson et al., 1998). As successful erythropoiesis is a prerequisite for
fetal survival, it has been suggested that abnormal erythropoiesis might be causally related
to embryo mortality during this time (Pearson et al., 1998).
Erythropoietin (EPO) is a glycosylated hormone and growth factor that is required for
successful erythropoiesis (Fisher, 1997). The primary stimulus for EPO production in adults
is tissue hypoxia (Jelkmann, 1992). It has been suggested that oxygen tension is sensed by
a heme protein (Goldberg et al., 1988; Galson et al., 1994) or non-heme protein (Srinivas
et al., 1998) that transduces the reduced oxygen signal into an increase in EPO mRNA that
is due primarily, but not exclusively, to increased transcription (Galson et al., 1994; Bunn
et al., 1998). Erythropoietin in most adult species is produced primarily by the peritubular
fibroblasts in the kidney cortex and outer medulla (Maxwell et al., 1990). During fetal
development, however, the site of EPO synthesis varies in a species-dependent manner. In
rodent species, EPO is synthesized primarily by the fetal liver throughout most of gestation
(Eckardt, 1995). In mice, a brief period of synthesis by the visceral yolk sac precedes that
in the liver (Rich et al., 1994). In sheep the liver and kidney are major sources by day 41
of gestation (Wintour et al., 1996). In addition, human placental trophoblast cells appear to
be a site of EPO production throughout most of gestation (Conrad et al., 1996).
Erythropoietin in the blood of porcine embryos has recently been measured (Pearson
et al., 1998) as early as day 30 of gestation (term = 114 days); however, the source of
this erythropoietin has not been determined. In the current studies, three different animal
models with differences in prenatal survival at 24–40 days of gestation were used to address
the following objectives: (1) determine if EPO mRNA is expressed in the porcine liver
(the predicted primary site of EPO expression) at days 24, 30, and 40 of gestation and
(2) determine if plasma EPO or liver EPO mRNA expression were related to embryonic
development at an age (day 35) when embryos were anticipated to be experiencing increased
mortality in a crowded uterine environment.
2. Materials and methods
2.1. Animals and tissue collections
White crossbred (WC) gilts either remained intact (INT) or were unilaterally hysterecto-
mized-ovariectomized (UHO) at approximately 160 days of age as previously described
(Christenson et al., 1987). Meishan (ME), INT, and UHO gilts were bred to boars of the
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same breed and randomly assigned to be slaughtered at days 24, 30, or 40 (initial study)
or day 35 (second study) of pregnancy. A total of 58 WC and 30 ME gilts were used for
both studies. WC gilts were bred at 262–320 days of age after at least one oestrous cycle of
normal length. ME gilts were bred at 272–308 days of age after more than seven oestrous
cycles. This ensured that an increased ovulation rate would occur in ME compared with
WC gilts (Christenson et al., 1993). Day 0 was designated as the first day of behavioral
oestrus. Pigs were maintained in groups of 10–20 in indoor swine facilities at the US Meat
Animal Research Center. Gilts received water ad libidum and 1.8–2.3 kg daily of a corn
and soybean-meal diet. For the initial study, reproductive tracts were removed at slaugh-
ter and fetal tissues subsequently obtained. Liver and placental samples were obtained
from random fetuses, rapidly frozen in liquid nitrogen, and stored at −80◦C until used
in assay procedures. Tissue removal began within 5 min of slaughter and continued until
fetuses within a tract were sampled (∼45 min). In the second study, pregnant gilts were
anesthetized initially with sodium Pentothal (1 g/gilt) administered I.V. and then main-
tained under 3–5% halothane:95–97% oxygen. A midventral laparotomy was performed
and uterine horns were gently exteriorized and covered with a sterile towel that was kept
constantly moist with warm (37◦C) sterile saline. A hysterotomy was then performed along
the antimesometrial border and one embryo exposed. A blood sample was obtained from
an umbilical artery, the embryo removed and weighed, and a small placental sample taken.
These latter procedures were repeated until all embryos in both uterine horns had been
exposed, sampled, and removed from the uterus. Embryos were dissected immediately and
liver and kidney tissue removed (kidney tissue was not taken from Meishan embryos). All
tissues were immediately frozen in liquid nitrogen. After all embryos were removed from
the uterus, a complete ovariectomy–hysterectomy was performed. In this latter study, mea-
sures were conducted specifically in two embryos of greatly divergent weights within each
gilt. It was our hypothesis that these two groups (large and small) would adequately rep-
resent those embryos that were developing normally (large embryos) and those that would
be experiencing developmental problems (small embryos). Blood samples were placed on
ice, centrifuged 1500×gav for 20 min, and plasma stored at−20◦C. All procedures involv-
ing use and slaughter of animals were approved by our institutional Animal Care and Use
Committee.
2.2. RNA extraction and RT-PCR
Total RNA was isolated from tissue samples using RNeasy Kits (QIAGEN, Chatsworth,
CA). Porcine cDNA for EPO, -actin, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (the latter two mRNA to be used to correct for RNA loading differences among
lanes) were then generated. To produce these cDNA reverse transcription (RT) was con-
ducted with previously prepared total RNA from neonatal pig kidney (EPO), adult pig kidney
(-actin), or uterine endometrium from day 30 of pregnancy (GAPDH) after treatment with
DNase (Promega Corp., Madison, WI), and purification on a QIAGEN RNeasy column.
The RT reactions for EPO and -actin used 2g RNA, 1l (1.6 ng) random nonamer
primers (Amersham, Arlington Heights, IL), 1l (200 units) Moloney Murine Leukemia
Virus (M-MLV) Reverse Transcriptase (Promega Corp.), 1l (40 units) RNasin ribonu-
clease inhibitor (Promega Corp.), 5l (10 mM) dNTPs (Promega Corp.), 8l M-MLV
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5 × reaction buffer (Promega Corp.), and sufficient diethyl pyrocarbonate-treated, auto-
claved water to give a final volume of 40l. The reaction mixture was incubated at 37◦C
for 60 min, then 95◦C for 5 min, and placed on ice. A cDNA for GAPDH was prepared as
previously described (Vallet et al., 1999).
Appropriate forward (5′ ACG CCT CAT CTG TGA CAG C 3′) and reverse (5′ ACA GCT
TTG TCC ACA TGC AG 3′) primers for porcine EPO were determined based on the known
sequence of the 3′ end of porcine EPO mRNA (Wen et al., 1993). Forward (5′ GAG ACC
TTC AAC ACG CCG 3′) and reverse (5′ GGA AGG TGG ACA GCG AGG 3′) primers for
porcine -actin, and forward (5′ CAC GAC CAT GGA GAA GGC 3′) and reverse (5′ GAA
GCA GGG ATG ATG TTC TGG 3′) primers for porcine GAPDH (Vallet et al., 1999) were
determined from a partial -actin sequence (GeneBank Sequence Database, Accession no.
U07786), and a complete GAPDH sequence (GeneBank Sequence Database, Accession no.
AF017079). Primers were synthesized using an Oligo 1000 M DNA Synthesizer (Beckman
Instruments, Inc., Fullerton, CA). Conditions for PCR included: (a) EPO; 1l each of
forward and reverse primers (20M), 2l dNTPs (2.5 mM dATP, dCTP, dGTP, dTTP),
2l 10 × buffer (Promega Corp.), 1.2l MgCl2 (Promega Corp., 25 mM), 1l (3.25 ng)
EPO cDNA template, 1l Taq DNA polymerase (Promega Corp.), and 10.8l sterile water
to provide a final volume of 20l. (b) -Actin was identical except that 2l (5 ng) of
cDNA primer and 9.8l sterile water were added. Thermocycler conditions for both were
94–95◦C× 4 min, 94–95◦C× 1 min, 60◦C× 1 min, 72◦C× 2 min, with the last three steps
repeated 29 times. Conditions for GAPDH were similar except the final volume was reduced
by 50%: 1l each of forward and reverse primers (20M), 1l cDNA template (1 ng),
1l 10 × buffer that contained 15M MgCl2, 1l dNTPs, 0.5l Taq polymerase, and
4.5l sterile water. Thermocycler conditions for GAPDH were 95◦C×1 min, 95◦C×15 s,
58◦C×1 min, 68◦C×1 min, with the last three steps repeated 29 times (Vallet et al., 1999).
2.3. Cloning
The cDNA from PCR reactions were purified via use of a QIAquick PCR Purification Kit
(QIAGEN), and then ligated into a pCRII plasmid vector and transformed into competent E.
coli cells (TOP10F′; Invitrogen, Carlsbad, CA). Colonies were screened by PCR, DNA iso-
lated from positive colonies, and then sequenced using primers specific for the pCRII vector
(M13 reverse primer, 5′ CAG GAA ACA GCT ATG AC 3′; M13 [−20] forward primer, 5′
GAC CGG CAG CAA AAT G 3′) and reagents associated with the BigDye Terminator Cycle
Sequencing Ready Reaction kit for sequencing on an ABI 377 automated DNA sequencer
(Perkin-Elmer Corp., Applied Biosystems Division, Foster City, CA). Characteristics of
cDNA produced for use in Northern analyses are presented in Table 1. The remainder of
the purified plasmid was digested using Eco RI (Promega) followed by purification of the
cDNA on a 1.2% agarose gel. The cDNA were cut from the gels and purified using the
QIAquick gel extraction kit (QIAGEN).
2.4. Northern analyses
Total RNA from liver, kidney, and placental samples was isolated as noted above and
20g (kidney) or 30g (liver, placenta) portions loaded onto denaturing MOPS 1.25%
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Table 1
Characteristics of cDNA for porcine EPO, -actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
CDNA No. of bp Approximate size of
hybridized mRNA
Percent homology with
known porcine sequence (%)
Reference
EPO 294 1800 98.6 Wen et al., 1993
-Actin 685 2600 98.3 GeneBank, no. U07786
GAPDH 324 1900 94.4 GeneBank, no. AF017079
agarose/formaldehyde gels. After electrophoresis, RNA was transferred by capillary blot-
ting to nylon membranes (Hybond-N, Amersham, Arlington Heights, IL) and fixed to the
membrane via UV crosslinking in a UV Stratalinker 2400 (Stratagene, LaJolla, CA). La-
beled cDNA was prepared using the above-noted specific forward and reverse primers for
each cDNA and PCR procedure that also included use of 32P-dCTP (Dupont New England
Nuclear, Wilmington, DE). After separating labeled cDNA from unincorporated 32P-dCTP,
labeled cDNA (≈1,000,000–1,5000,000 dpm/ml hybridization buffer) was added to ny-
lon membranes containing crosslinked RNA that were prehybridized for 1 h at 60◦C in
10 ml/membrane of Rapid-hyb buffer (Amersham). The hybridization reaction continued
for 2 h at 65◦C. Membranes were then washed twice with 2 × 0.3 M sodium chloride,
0.03 M sodium citrate pH 7.0 (SSC) containing 0.1% sodium lauryl sulfate (SDS) at 42◦C
for 30 min. Additional washes with decreasing concentrations of SSC (0.5–0.1×) and in-
creasing temperatures (60–65◦C) were used to wash nonspecifically-bound radioactivity
from the membranes. Membranes were then exposed to X-ray film (Eastman Kodak Co.,
Rochester, NY) at −80◦C for 2 weeks (EPO) or approximately 24 h (-actin, GAPDH).
Densitometry measurements were conducted for EPO with a Ultrascan XL (Pharmacia
LKB Biotechnology Inc., Piscataway, NJ) or with a ChemiImager (Alpha Innotech Corp.,
San Leandro, CA) for -actin and GAPDH.
2.5. Erythropoietin RIA
A heterologous RIA procedure (Diagnostic Systems Laboratories, Webster, TX) previ-
ously validated for use with pig plasma (Pearson et al., 1998) was used to measure con-
centrations of EPO in embryonic pig plasma in Experiment II. All samples were analyzed
in duplicate 50l volumes in a single assay with an average CV of 5.8% and an assay
sensitivity (lowest standard in the linear range of the standard curve) of 0.25 mU per tube.
Data are presented as mU/ml relative to a human EPO standard.
2.6. Statistics
Each Northern blot consisted of each treatment × day of gestation combination and,
therefore, constituted a block or replicate of the experiment. Densitometric measures for
each experimental sample EPO mRNA were then analyzed by analysis of covariance using
-actin densitometric measures for the same sample as a covariate and using the PROC
MIXED procedure of the Statistical Analysis System (SAS, 1997) that included blocks as
a random term. Linear relationships among measures were analyzed using PROC MIXED
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and analysis of covariance procedures. All data were tested for homogeneity of variance
with an F max test, and data transformed to a log function where necessary. Least square
means ± S.E.M. of original data are always presented. A probability level of ≤0.05 was
considered significant.
3. Results
3.1. Experiment I
Effects of treatments (animal models or gestational age) on fetal numbers, size, and
survival have been previously reported for this study (Pearson et al., 1998). Briefly, fetal
numbers on days 30 and 40 were greater in INT versus UHO (P < 0.01) and did not differ
between INT and ME. Fetal weights were greater in WC (INT and UHO) versus ME at each
day of gestation (P < 0.01). Percent survival was reduced (P < 0.05) in UHO compared
with INT and ME on day 40.
Steady-state amounts of EPO mRNA in fetal liver appeared to be greatest on day 24
and decreased (P < 0.001) with gestational age (Figs. 1 and 2a). There were, however, no
treatment-associated differences at the ages measured (P < 0.63). Data for EPO presented
in Fig. 2a are adjusted via analysis of covariance to -actin. If instead EPO is adjusted for
Fig. 1. Representative Northern analysis of EPO, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and
-actin mRNA from embryonic pig liver at various gestational ages. All lanes consisted of 30g total RNA.
WC-INT: intact white crossbred gilts; WC-UHO: unilaterally-hysterectomized-ovariectomized white crossbred
gilts; ME: intact Meishan gilts.
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Fig. 2. (A) Results of densitometric analyses of steady-state levels of embryonic porcine liver erythropoietin
mRNA. Results represent least squares means + S.E.M. Each experimental sample was adjusted by analysis of
covariance using the absorbancy of the -actin for the same sample as a covariate. Densitometric analyses of (B)
glyceraldehyde phosphate dehydrogenase (GAPDH) and (C) -actin are presented without adjustments. Numbers
in parentheses represent the number of fetuses (one fetus/gilt) incorporated into each least-squares mean and
S.E.M. One lane for a day-40 ME fetus was not readable by densitometric procedures and was not used, therefore,
in 2A, n = 5 for day-40 ME. Measures for GAPDH were conducted on one additional ME fetus on day 24 and
hence n = 7 in 2B. Statistics were performed on log-transformed data for erythropoietin mRNA. There were no
treatment × day interactions (P > 0.47).
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Fig. 3. Representative Northern analysis of EPO, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and
-actin mRNA from embryonic pig placental tissue at various gestational ages. All lanes consisted of 30g
total RNA. WC-INT: intact white crossbred gilts; WC-UHO: unilaterally-hysterectomized-ovariectomized white
crossbred gilts; ME: intact Meishan gilts.
GAPDH, very similar data and identical interpretations are obtained (data not shown). In
placental tissue, EPO mRNA was present in a few day 24 and day 30 placentae (Fig. 3)
in an apparently random manner (1 × day 24 INT, 1 × day 30 INT, 1 × day 30 ME, and
1× day 30 UHO).
Both -actin and GAPDH were highly expressed in embryonic liver and placental tissue
(Figs. 1–3). For -actin two transcripts were present: a major transcript at approximately
2600 bp, and a minor transcript at 1800 bp. The major transcript was used for calculations
and statistical evaluations. Both mRNA decreased modestly but significantly (P < 0.01) in
liver after day 24 in all treatments (-actin 29% decrease; GAPDH 19.4% decrease). There
were no treatment effects on amounts of liver -actin or GAPDH mRNA expression.
3.2. Experiment II
In Experiment I, it appeared that considerable embryonic death occurred between days
30 and 40 of gestation in UHO gilts (Pearson et al., 1998). Hence, a second study was
conducted at day 35 when more embryos might be alive but undergoing developmental
inadequacies that would cause their death within several days.
Embryonic weights did not differ between WC-INT and WC-UHO, but Meishan embryos
were lighter than WC-INT, and for each pig model were less in the small versus large size
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Table 2
Measures in porcine embryos at day 35 of gestation
Pig model Embryonic
size
(group)
na Embryonic
weight (g)
Placental
weight (g)
No. of
corpora
lutea
No. of live
embryos
Percent
survival
WC-INT Large 14 4.1 ± 0.2 38.7 ± 3.4
14.4 ± 0.6 11.0 ± 0.6 77.1 ± 3.9
Small 14 3.4 ± 0.2 29.0 ± 3.4
WC-UHO Large 9 3.9 ± 0.2 28.0 ± 4.0
14.0 ± 0.8 10.7 ± 0.8 73.1 ± 5.2
Small 9 3.1 ± 0.2 14.7 ± 4.0
ME Large 13 3.4 ± 0.2 25.1 ± 3.4
14.7 ± 0.6 12.7 ± 0.7 86.6 ± 4.3
Small 13 2.9 ± 0.2 20.4 ± 3.4
ANOVA Evaluation
Pig model P = 0.09 P = 0.02 0.79 0.11 P = 0.12
Size P < 0.001 P < 0.001 – – –
Interaction P = 0.08 P = 0.34 – – –
A Priori Contrasts
WC-INT vs. ME P = 0.03 P = 0.02 – – –
WC-INT vs. WC-UHO P = 0.48 P = 0.01 – – –
WC vs. ME – – – P = 0.04 P = 0.04
a Here, n represents the number of fetuses (1 large and 1 small per gilt) associated with each pig model,
embryonic size group.
Fig. 4. Plasma erythropoietin concentrations in pig embryos at day 35 of gestation. Units are expressed rela-
tive to a human erythropoietin standard. Numbers in parentheses represent the number of embryos (one em-
bryo/embryonic size/gilt) used in each least-squares mean and S.E.M. WC-INT: intact white crossbred gilts;
WC-UHO: unilaterally-hysterectomized-ovariectomized white crossbred gilts; ME: intact Meishan gilts. There
was no interaction between pig model and size (P > 0.49).
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Fig. 5. (A) Representative Northern analysis of EPO and -actin mRNA from embryonic pig liver at day 35 of
gestation. All lanes consisted of 30g total RNA. (B) Results of densitometric analyses of steady-state levels of
embryonic liver erythropoietin mRNA at day 35 of gestation. Results represent least squares mean+S.E.M. Each
erythropoietin measure was adjusted by analysis of covariance using the absorbancy of the -actin for the same
sample as a covariate. Numbers in parentheses represent the number of embryos (one embryo/embryonic size/gilt)
used in each least-squares mean and S.E.M. There was no interaction between pig model and size (P = 0.47).
WC-INT: intact white crossbred gilts; WC-UHO: unilaterally-hysterectomized-ovariectomized white crossbred
gilts; ME: intact Meishan gilts.
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groups (Table 2). Placental weights were smaller not only in smaller fetuses within each ani-
mal model but also in Meishan versus WC-INT and in WC-UHO versus WC-INT (Table 2).
The number of ovulations as measured by the number of viable corpora lutea at slaughter
did not differ among pig models (Table 2). The number of live embryos was greater in ME
gilts when compared with WC gilts using a priori contrasts (Table 2). Embryonic survival
in ME gilts was greater than in WC gilts (Table 2). Plasma erythropoietin concentrations
did not differ between embryonic size groups (P = 0.27) but were 33% lower (P = 0.002)
in ME versus WC embryos (Fig. 4). Liver EPO mRNA expression were low but present
on day 35 (Fig. 5a) and did not differ among animal models or embryonic weight groups
(Fig. 5b). Liver EPO mRNA expression was not associated with plasma EPO concentra-
tions (P = 0.31) nor with fetal (P = 0.46), placental (P = 0.84), or liver (P = 0.18)
weights. Plasma EPO concentrations were similarly not associated with fetal (P = 0.78),
placental (P = 0.28), or liver weights (P = 0.69). EPO mRNA expression could not be
detected at this gestational age in placental tissue using Northern hybridization techniques.
In kidney RNA preparations, EPO mRNA was barely discernable but not quantifiable in a
few embryos (data not shown).
4. Discussion
In pigs, these results are the first to indicate a liver source of fetal erythropoietin during
early gestation although the data do not rule out additional sources. As has been established
in other species (Galson et al., 1994; Lim et al., 1994; Eckardt, 1995; Wintour et al., 1996),
the porcine fetal liver expresses EPO mRNA at an early prenatal developmental stage.
The approximately 1800 bp size of the porcine mRNA corresponds reasonably well to the
EPO mRNA for rat (1395 bp; Nagao et al., 1992), human fetal (1342 bp; Jacobs et al.,
1985), monkey (1462 bp; Lin et al., 1986), and bovine species (1258 bp; Suliman et al.,
1996). Decreasing levels of steady-state EPO mRNA expression between days 24 and 40
closely parallel the decrease in plasma EPO concentrations that we previously reported
(Pearson et al., 1998). Observed decreases in liver EPO mRNA were somewhat modified
by using amounts of -actin and GAPDH mRNA expression as covariates as these were
modestly but significantly reduced with fetal age. Hence their use, although permitting
adjustment for lane-loading differences, produced more conservative evaluations of EPO
mRNA age-related differences.
The cause of this age-related decrease in liver EPO mRNA is not known but four possi-
bilities exist. One possibility is the changing profile of embryonic hemoglobins known to
occur in porcine embryos at about this time (Weber et al., 1987). The percentages of these
four hemoglobins, Gower I, Gower II, Heide I, and Heide II, decreases dramatically from
approximately 25 to 35 days of gestation concomitant with a dramatic increase in adult
hemoglobin A (Weber et al., 1987). As embryonic hemoglobins are produced in nucleated
red blood cells (Kitchen and Brett, 1974), this decrease coincides with the maturation of the
blood profile of erythrocytes and their precursors (Pearson et al., 1998). The Gower I and
Heide I forms predominate in earlier embryos and have a greater oxygen affinity, thereby
increasing the efficacy of transfer of oxygen from the maternal to embryonic circulation
(Weber et al., 1987) while also providing less oxygen to tissues at a given partial pressure
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of oxygen (Jelkmann, 1992). In rats, this phenomenon led to increases in plasma erythro-
poietin (Lechermann and Jelkmann, 1985). Hence, higher liver EPO mRNA in day-24
embryos may reflect the presence of embryonic hemoglobins. A second possibility is that
dramatic increases in total numbers of red blood cells (mature and immature) at this time
(Pearson et al., 1998) provides more oxygen to tissues with a subsequent decrease in EPO
production.
Thirdly, synthesis of EPO may shift from the liver to another tissue at a much earlier age
in pigs than in other species. However, we could not detect any significant expression of
kidney (the most logical next site of EPO synthesis) EPO mRNA using Northern analyses. In
mice at about 19 days of gestation (term = 20 days), the kidney appears to assume the major
role of EPO production (Koury et al., 1988) whereas in rats the liver is the predominant
source of EPO until 28 days of neonatal life (Eckardt et al., 1992). In fetal sheep, the fetal
kidney appears to be involved in EPO synthesis as early as day 41 (0.28 gestational length;
Wintour et al., 1996). Fetal sheep liver EPO mRNA expression declines after day 60 of
gestation (term = 145 days) whereas kidney EPO mRNA expression remains constant
between days 60 and 100 and then declines to lesser amounts at 140 days (Lim et al.,
1994).
Finally, age-related decreases in liver EPO mRNA expression may reflect the fact that at
day 24, expression is constitutive and by day 30, expression is at least in part regulated by
blood oxygen content. Such a phenomenon was apparent in fetal rats wherein at days 15
and 16 of gestation liver EPO was uninfluenced by hypoxia but after day 17 underwent an
age-related decline in controls and increased in oxygen-deprived rats (Clemons et al., 1986).
Once oxygen-associated control of EPO mRNA expression is established, expression under
normoxic conditions is quite low to unmeasurable (Koury et al., 1989; Eckardt et al., 1992;
Fu et al., 1993).
The current results also suggest the presence of placental EPO mRNA. This expression
was very limited on day 24 and 30 and by days 35 and 40 could not be detected. Conrad et al.
(1996) demonstrated immunoreactive EPO in the cytotrophoblasts and syncytiotrophoblasts
of first- and second-trimester human placentae and in syncytiotrophoblasts of third-trimester
placentae. However, RT-PCR was needed to detect placental EPO mRNA. Current results
suggest the possibility that the porcine placenta during early pregnancy is an additional site
of EPO production.
Oxygen is required by all living cells and is transported in the blood bound to hemoglobin
found in erythrocytes and their precursors. In order to ensure cells have an adequate sup-
ply of oxygen, erythropoiesis is tightly coupled via EPO to oxygen tension (Huang and
Bunn, 1995). EPO is a crucial growth factor required for normal erythropoiesis; in mice,
homozygous for null mutations of EPO, erythropoiesis is greatly reduced and these em-
bryos die about day 13 of gestation (Wu et al., 1995; Lin et al., 1996). Hence, if abnormal
EPO mRNA expression were occurring, one would expect low EPO mRNA concomitant
with low circulating EPO and reduced hemoglobin and hematocrit. Such associations, if
prolonged and of sufficient magnitude, would ultimately lead to low oxygen availabil-
ity and eventually cellular and embryonic death. Such associations were not apparent in
our studies. If on the contrary, hypoxia were occurring due to other mechanisms such
as reduced utero-placental blood flow or placental inadequacies (Maier et al., 1994) in
the presence of a functional EPO sensing and production system, one might expect —
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depending on the rapidity and severity of the hypoxia — to measure increased EPO mRNA
(Fu et al., 1993; Darby et al., 1995; Lim et al., 1996), plasma EPO (Kitanaka et al., 1989;
Fu et al., 1993; Maier et al., 1993, 1994), and concomitantly increased hemoglobin and
hematocrit (Kitanaka et al., 1989; Fu et al., 1993). In some experimental paradigms due
to a time-lag in the stimulus-response coupling, there are significant negative associations
between plasma EPO or EPO mRNA expression and red blood cell mass (Walle et al.,
1987; Koury et al., 1989) or hemoglobin (Kling et al., 1996). These relationships were not
observed. Our data suggest, therefore, that in the embryos measured, EPO production (as
reflected by tissue mRNA and plasma concentrations) was not compromised and levels
present represent normal variability among animals. These data also suggest that either
oxygen availability was not compromised in these embryos, or that the oxygen sensing
system and/or its coupling to EPO production was not yet functional. Strong relation-
ships among EPO mRNA, plasma EPO, hematocrit and hemoglobin have been previously
reported when animals have been made hypoxic and EPO production is stimulated (Ki-
tanaka et al., 1989; Koury et al., 1989; Tan et al., 1992; Fu et al., 1993; Darby et al.,
1995).
A factor that potentially influences our results and their interpretation is the limited
number of fetuses sampled per gilt in our first study. An increased number of fetuses per
gilt might have allowed detection of differences among animal models and perhaps improved
the accuracy of results. In the second study, we attempted to address this issue by increasing
the number of gilts in each treatment and by sampling two fetuses per gilt. It is also worthy
of mention that in our second study at day 35, there were no differences in fetal survival
between UHO and INT gilts as occurred at day 40 in the first experiment. This suggests
that losses in the first study occurred after day 35.
Previous studies have indicated associations among intrauterine growth retardation, hy-
poxia, and EPO. In hypoxemic sheep, growth retardation of fetuses was observed (Ja-
cobs et al., 1986). Umbilical blood EPO concentrations in some human newborns in-
dicated prolonged fetal hypoxia and were significantly correlated with fetal growth re-
tardation (Maier et al., 1993). Small-for-gestational-age human fetuses (18–36 weeks of
gestation) were hypoxemic (Nicolaides et al., 1989), and small-for-gestational-age human
fetuses (24–36 weeks of gestation) had greater umbilical blood EPO concentrations than
adequate-for-gestational-age fetuses (Lemery et al., 1994). Hence, in the current study, it
was hypothesized that smaller embryos within a pig model might be challenged in terms
of oxygen availability and potential survival and that altered EPO might be associated with
this condition. However, there were no measurable associations between fetal or placental
size and tissue EPO mRNA or plasma EPO concentrations. Again, an adequate oxygen
supply was suggested in all living embryos irrespective of size.
In summary, porcine embryonic liver provides one source of plasma EPO as evidenced by
the presence of EPO mRNA in this tissue. Porcine placenta may also represent a source of
EPO on days 24–30. Kidney EPO mRNA was measured only on day 35 and was essentially
absent. Hence, it is not known when measurable EPO mRNA expression appears in this
tissue. In the live embryos measured, EPO mRNA expression and plasma concentrations
were not associated with embryonic size, and there was no obvious positive association
with survival. Such data suggest normal EPO transcription or translation and an absence of
hypoxia in living embryos during this gestational period.
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